Genomtec S.A. (FRA:4VI)
Germany flag Germany · Delayed Price · Currency is EUR
0.941
-0.004 (-0.42%)
Last updated: Dec 5, 2025, 9:59 AM CET

Genomtec Company Description

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

The company’s flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysis of biological material of patients using swabs, urine, and saliva.

It also develops SNAAT chemistry for mutation detection in oncology. In addition, the company develops and commercializes tests used in the detection of viral infectious diseases and other areas.

Genomtec S.A. was incorporated in 2008 and is based in Wroclaw, Poland.

Genomtec S.A.
Country Poland
Founded 2008
Industry Biological Products, Except Diagnostic Substances
Employees 26
CEO Miron Tokarski

Contact Details

Address:
Bierutowska Street 57-59
Wroclaw, 51-317
Poland
Website genomtec.com

Stock Details

Ticker Symbol 4VI
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency PLN
SIC Code 2836

Key Executives

Name Position
Miron Tokarski Chief Executive Officer
Michal Wachowski Chief Financial Officer